Expert consensus on neoadjuvant treatment of breast cancer in China (2021 edition)
Neoadjuvant therapy has become one of the standard treatments in early breast cancer. In 2019, China breast cancer neoadjuvant therapy expert group discussed and expounded the purpose, indication, evaluation criteria, surgical operation principles and the treatment strategy of neoadjuvant therapy. W...
| 第一著者: | |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
Editorial Office of China Oncology
2022-01-01
|
| シリーズ: | Zhongguo aizheng zazhi |
| 主題: | |
| オンライン･アクセス: | http://www.china-oncology.com/fileup/1007-3639/PDF/1643099040828-1468604485.pdf |